TERRI-ANN BROWN: Open Payments
NPI 1437436433 · WILTON MANORS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,013 in 62 payments from 12 companies in 2025. Trend: 2023 $1,776 · 2024 $1,122 · 2025 $2,013
Food & beverage: $2,013
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $312 |
| E.R. Squibb & Sons, L.L.C. | 10 | $279 |
| Axsome Therapeutics, Inc. | 5 | $275 |
| Teva Pharmaceuticals USA, Inc. | 5 | $223 |
| Neurocrine BioSciences, Inc. | 3 | $206 |
| Lundbeck LLC | 10 | $167 |
| Luye Pharma (USA) Ltd. | 3 | $155 |
| Supernus Pharmaceuticals, Inc. | 1 | $119 |
| Alkermes, Inc. | 6 | $116 |
| ABBVIE INC. | 4 | $96 |
Products named: REXULTI, COBENFY, Auvelity, UZEDY, INGREZZA, ERZOFRI EXTENDED-RELEASE, Qelbree, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
